HCM II Acquisition [HOND] vs Eqv Ventures [EQV] Detailed Stock Comparison
HCM II Acquisition
Eqv Ventures
TLDR: Quick Comparison Summary
Based on 6 vital metrics comparison: HCM II Acquisition wins in 2 metrics, Eqv Ventures wins in 1 metrics, with 3 ties. HCM II Acquisition appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Note: Limited metrics are available for comparison. Check other tabs for more detailed analysis.
| Metric | HCM II Acquisition | Eqv Ventures | Better |
|---|---|---|---|
| Price-to-Book Ratio | 2.18 | 1.32 | Eqv Ventures |
| Debt-to-Equity Ratio | 0.00 | 0.00 | Tie |
| Profit Margin (TTM) | 0.00% | 0.00% | Tie |
| Operating Margin (TTM) | 0.00% | 0.00% | Tie |
| 1-Year Return | 72.29% | 4.95% | HCM II Acquisition |
| Enterprise Value | $485.18M | $462.18M | HCM II Acquisition |
HCM II Acquisition vs Eqv Ventures Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| HCM II Acquisition | 4.14% | 8.54% | 49.09% | 54.59% | 63.43% | 71.09% |
| Eqv Ventures | -0.19% | 0.00% | 0.10% | -1.33% | 2.97% | 4.21% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| HCM II Acquisition | 72.29% | 72.29% | 72.29% | 72.29% | 72.29% | 72.29% |
| Eqv Ventures | 4.95% | 4.74% | 4.74% | 4.74% | 4.74% | 4.74% |
News Based Sentiment: HCM II Acquisition vs Eqv Ventures
HCM II Acquisition
News based Sentiment: NEUTRAL
The month's primary event was the completion of a business combination and subsequent public listing of Daseke, Inc. This is a significant corporate event, but its impact on investment prospects is yet to be determined, making the overall sentiment neutral. The redemption of shares provides a clear outcome for existing investors.
Eqv Ventures
News based Sentiment: MIXED
September saw positive developments for EQV Ventures with the continued progress towards the Presidio merger and increased institutional investment. However, cautious forecasts, a lack of analyst coverage, and limited insider activity data create a mixed picture for investors, suggesting a need for careful monitoring and a balanced approach.
Performance & Financial Health Analysis: HCM II Acquisition vs Eqv Ventures
| Metric | HOND | EQV |
|---|---|---|
| Market Information | ||
| Market Cap | $493.35M | $463.55M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 3,079,671 | 68,600 |
| 90 Day Avg. Volume | 1,477,824 | 42,587 |
| Last Close | $17.87 | $10.37 |
| 52 Week Range | $9.90 - $18.80 | $9.88 - $10.74 |
| % from 52W High | -4.95% | -3.45% |
| All-Time High | $18.80 (Oct 06, 2025) | $10.74 (Jun 16, 2025) |
| % from All-Time High | -4.95% | -3.45% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.00% |
| Operating Margin (TTM) | 0.00% | 0.00% |
| Return on Equity (TTM) | N/A | N/A |
| Debt to Equity (MRQ) | 0.00 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-0.49 | $-0.30 |
| Cash per Share (MRQ) | $0.00 | $0.02 |
| Operating Cash Flow (TTM) | $-323,234 | $-1,057,380 |
| Levered Free Cash Flow (TTM) | $0 | $0 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: HCM II Acquisition vs Eqv Ventures
| Metric | HOND | EQV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | N/A | N/A |
| Price to Book (MRQ) | 2.18 | 1.32 |
| Market Capitalization | ||
| Market Capitalization | $493.35M | $463.55M |
| Enterprise Value | $485.18M | $462.18M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | N/A | N/A |
| Enterprise to EBITDA | N/A | N/A |
| Risk & Other Metrics | ||
| Beta | N/A | N/A |
| Book Value per Share (MRQ) | $-0.49 | $-0.30 |
Financial Statements Comparison: HCM II Acquisition vs Eqv Ventures
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HOND | EQV |
|---|---|---|
| Revenue/Sales | $0 | $0 |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-278,494 | $-332,208 |
| EBITDA | $-278,494 | $-332,208 |
| Pre-Tax Income | $1.07M | $2.96M |
| Income Tax | N/A | N/A |
| Net Income (Profit) | $1.07M | $2.96M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HOND | EQV |
|---|---|---|
| Cash & Equivalents | $517,160 | $1.07M |
| Total Current Assets | $682,955 | $1.20M |
| Total Current Liabilities | $1.40M | $1.01M |
| Long-Term Debt | N/A | N/A |
| Total Shareholders Equity | $225.58M | $347.07M |
| Retained Earnings | $-12.08M | $-12.63M |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HOND | EQV |
|---|---|---|
| Operating Cash Flow | $-273,494 | $-332,208 |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $-294,130 | $-363,595 |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HOND | EQV |
|---|---|---|
| Shares Short | 45,339 | 987 |
| Short Ratio | 0.10 | 0.03 |
| Short % of Float | 0.00% | 0.00% |
| Average Daily Volume (10 Day) | 3,079,671 | 68,600 |
| Average Daily Volume (90 Day) | 1,477,824 | 42,587 |
| Shares Outstanding | 28.75M | 44.57M |
| Float Shares | 21.05M | 23.53M |
| % Held by Insiders | 0.00% | 0.02% |
| % Held by Institutions | 0.99% | 0.84% |
Dividend Analysis & Yield Comparison: HCM II Acquisition vs Eqv Ventures
| Metric | HOND | EQV |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |